Publikácie

  1. Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers. Zavodna K, Krivulcik T, Bujalkova MG, Slamka T, Martinicky D, Ilencikova D, Bartosova Z. BMC Cancer. 2009 Nov, 20;9:405. PubMed PMID: 19930554
  2. Frequency of the three most common polymorphisms in the MDR1 gene in Slovak population. Krivulcik T, Sedlak J, Bartosova Z. Neoplasma. 2009;56(2):101-7. PubMed PMID: 19239322.
  3. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors. Bujalkova M, Zavodna K, Krivulcik T, Ilencikova D, Wolf B, Kovac M, Karner-Hanusch J, Heinimann K, Marra G, Jiricny J, Bartosova Z. Clin Chem. 2008 Nov;54(11):1844-54. PubMed PMID: 18772310.
  4. Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques. Konecny M, Zavodna K, Vranova V, Vizvaryova M, Weismanova E, Mlkva I, Kuglik P, Kausitz J, Bartosova Z. Breast Cancer Res Treat. 2008 Jun;109(3):581-3. PubMed PMID:17661172.
  5. Novel approaches in evaluation of pathogenicity of single-base exonic germline changes involving the mismatch repair genes MLH1 and MSH2 in diagnostics of Lynch syndrome. Gerykova-Bujalkova M, Krivulcik T, Bartosova Z. Neoplasma. 2008;55(6):463-71. Review. PubMed PMID: 18999873.
  6. The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis. Alemayehu A, Tomkova K, Zavodna K, Ventusova K, Krivulcik T, Bujalkova M, Bartosova Z, Fridrichova I. Neoplasma. 2007;54(5):391-401. PubMed PMID: 17688369.
  7. STK11/LKB1 germline mutations in the first Peutz-Jeghers syndrome patients identified in Slovakia. Bartosova Z, Zavodna K, Krivulcik T, Usak J, Mlkva I, Kruzliak T, Hromec J, Usakova V, Kopecka I, Veres P, Bartosova Z, Bujalkova M. Neoplasma. 2007;54(2):101-7. PubMed PMID: 17319781.
  8. Apoptotic effect of ethyl-4-isothiocyanatobutanoate is associated with DNA damage, proteasomal activity and induction of p53 and p21cip1/waf1. Bodo J, Jakubikova J, Chalupa I, Bartosova Z, Horakova K, Floch L, Sedlak J. Apoptosis. 2006 Aug;11(8):1299-310. PubMed PMID: 16830228.
  9. Identification of phenylethanolamine N-methyltransferase gene expression in stellate ganglia and its modulation by stress. Kubovcakova L, Micutkova L, Bartosova Z, Sabban EL, Krizanova O, Kvetnansky R. J Neurochem. 2006 Jun;97(5):1419-30. PubMed PMID: 16696852.
  10. Peutz-jeghers syndrome (PJS) – disease genetically diagnosed at the edge of the 21st century (in Slovak) Peutz-Jeghersov syndróm (PJS)-ochorenie geneticky diagnostikované na prelome 21. storočia. Ušák J, Kružliak T, Ušáková V, Bartošová Z, Hromec J, Kopecká I, Vereš P: Interná medicína 11, 2006, p. 598-601.
  11. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia. Zavodna K, Bujalkova M, Krivulcik T, Alemayehu A, Skorvaga M, Marra G, Fridrichova I, Jiricny J, Bartosova Z. Neoplasma. 2006;53(4):269-76. PubMed PMID: 16830052.
  12. The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation. Czako L, Tiszlavicz L, Takács R, Baradnay G, Lonovics J, Cserni G, Zavodna K, Bartosova Z. Orv Hetil. 2005 May 15;146(20):1009-16. Hungarian. PubMed PMID: 15945244.
  13. Peutz-Jeghers syndrome – diagnostics and management. Peutz-Jeghersov syndróm – diagnostika a manažment. Ušák J, Hromec J, Bartošová Z, Vojtech I, Ušáková V, Kružliak T: Gastroenterológia pre prax 2005; 4, p. 38-40.
  14. The Escherichia coli RecA protein complements recombination defective phenotype of the Saccharomyces cerevisiae rad52 mutant cells. Dudas A, Markova E, Vlasakova D, Kolman A, Bartosova Z, Brozmanova J, Chovanec M. Yeast. 2003 Apr 15;20(5):389-96. PubMed PMID: 12673622.
  15. Hereditary colorectal cancer – concept of clinico – genetical surveillance. Ilenčíková D, Bartošová Z, Fridrichová I, Bujalková M, Križan P: Gastroenterológia pre prax 2, p. 189-195, 2003.
  16. Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Bartosova Z, Fridrichova I, Bujalkova M, Wolf B, Ilencikova D, Krizan P, Hlavcak P, Palaj J, Lukac L, Lukacova M, Böör A, Haider R, Jiricny J, Nyström-Lahti M, Marra G. Hum Mutat. 2003 Apr;21(4):449. PubMed PMID: 12655568.
  17. Using molecular genetic diagnostic in the prevention of colorectal cancer. Ilenčíková D, Fridrichová I, Bartošová Z, Zajac V: Lekársky obzor 51, p. 19-24, 2002
  18. Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. Marra G, D’Atri S, Corti C, Bonmassar L, Cattaruzza MS, Schweizer P, Heinimann K, Bartosova Z, Nyström-Lahti M, Jiricny J. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7164-9. PubMed PMID: 11416201; PubMed Central PMCID: PMC34640.
  19. Mutation screening of the BRCA1 gene in Slovak patients. Tomka M, Sedlakova O, Reinerova M, Veselovska Z, Stevurková V, Bartosova Z, Zajac V. Neoplasma. 2001;48(6):451-5. PubMed PMID: 11949836.
  20. Approaches to identification of HNPCC suspected patients in Slovak population.Fridrichova I, Ilencikova D, Friedl W, Hlavcak P, Skorvaga M, Krizan P, Palaj J, Pirsel M, Farkasova E, Bartosova Z. Neoplasma. 2000;47(4):219-26. PubMed PMID: 11043825.
  21. Radiation-induced apoptosis and cell cycle alterations in human carcinoma cell lines with different radiosensitivities. Hunáková L, Chorváth M, Duraj J, Bartosova Z, Sevcíková L, Suliková M, Chovancová J, Sedlák J, Chorváth B, Boljesíková E. Neoplasma. 2000;47(1):25-31. PubMed PMID: 10870683.
  22. Lack of correlation between repair of DNA interstrand cross-links and differential sensitivity of G0 and proliferating CD4+ lymphocytes towards cisplatin. Bartosova Z, Horak ID, Pirsel M, Bohr VA. Neoplasma. 1999;46(6):342-8. PubMed PMID: 10732862.
  23. Gene-specific repair in human CD4+ lymphocytes reflects transcription and proliferation. Bartosova Z, Pirśel M, Reinhold W, Stetler-Stevenson M, Zajac-Kaye M, May A, Horak ID, Bohr VA. Mutat Res. 1996 Aug 8;363(3):191-9. PubMed PMID: 8765160.
  24. Transcription affects the rate but not the extent of repair of cyclobutane pyrimidine dimers in the human adenosine deaminase gene. Venema J, Bartosova Z, Natarajan AT, van Zeeland AA, Mullenders LH. J Biol Chem. 1992 May 5;267(13):8852-6. PubMed PMID: 1577723.